April 01, 2016 - MM&M - Medical Marketing and Media

Print Issue: April 01, 2016

Top 25 respiratory products, 2014-2015

GlaxoSmithKline’s Advair brought in $4.8 billion in U.S. sales in 2015, edging out Boehringer Ingelheim’s Spiriva Handihaler ($3.4 billion) and AstraZeneca’s Symbicort ($2.6 billion).